JP2006516655A - 腫瘍の診断と治療のための組成物と方法 - Google Patents

腫瘍の診断と治療のための組成物と方法 Download PDF

Info

Publication number
JP2006516655A
JP2006516655A JP2006503409A JP2006503409A JP2006516655A JP 2006516655 A JP2006516655 A JP 2006516655A JP 2006503409 A JP2006503409 A JP 2006503409A JP 2006503409 A JP2006503409 A JP 2006503409A JP 2006516655 A JP2006516655 A JP 2006516655A
Authority
JP
Japan
Prior art keywords
antibody
tat
polypeptide
cells
antibodies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2006503409A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006516655A5 (enExample
Inventor
グレッチェン フランツ，
ケニス ヒラン，
ポール ポラキス，
ベニ ウォルフ，
トーマス ウー，
ツオーミン ツァン，
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genentech Inc
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of JP2006516655A publication Critical patent/JP2006516655A/ja
Publication of JP2006516655A5 publication Critical patent/JP2006516655A5/ja
Withdrawn legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2006503409A 2003-02-05 2004-02-05 腫瘍の診断と治療のための組成物と方法 Withdrawn JP2006516655A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US44539603P 2003-02-05 2003-02-05
PCT/US2004/003607 WO2004071530A2 (en) 2003-02-05 2004-02-05 Identification of cellular polypeptides differentially expressed by tumor cells

Publications (2)

Publication Number Publication Date
JP2006516655A true JP2006516655A (ja) 2006-07-06
JP2006516655A5 JP2006516655A5 (enExample) 2007-03-29

Family

ID=32869357

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006503409A Withdrawn JP2006516655A (ja) 2003-02-05 2004-02-05 腫瘍の診断と治療のための組成物と方法

Country Status (10)

Country Link
US (3) US20040258696A1 (enExample)
EP (1) EP1589997A2 (enExample)
JP (1) JP2006516655A (enExample)
KR (1) KR20050105459A (enExample)
AU (1) AU2004211958A1 (enExample)
CA (1) CA2515115A1 (enExample)
MX (1) MXPA05008293A (enExample)
NZ (1) NZ542206A (enExample)
WO (1) WO2004071530A2 (enExample)
ZA (1) ZA200506507B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105316405A (zh) * 2003-07-17 2016-02-10 环太平洋生物技术有限公司 用于胃癌检测的标记物
NZ568015A (en) 2005-12-08 2012-03-30 Medarex Inc Human monoclonal antibodies to O8E
US20090011060A1 (en) * 2007-07-06 2009-01-08 Peter Koepke Campsiandra angustifolia extract and methods of extracting and using such extract
US7879369B2 (en) 2007-09-18 2011-02-01 Selvamedica, Llc Combretum laurifolium Mart. extract and methods of extracting and using such extract
US10260089B2 (en) 2012-10-29 2019-04-16 The Research Foundation Of The State University Of New York Compositions and methods for recognition of RNA using triple helical peptide nucleic acids

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001016318A2 (en) * 1999-09-01 2001-03-08 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US6011012A (en) * 1995-06-05 2000-01-04 Human Genome Sciences, Inc. Human cystatin E
WO2000052204A2 (en) * 1999-02-22 2000-09-08 Orntoft Torben F Gene expression in bladder tumors
US6974667B2 (en) * 2000-06-14 2005-12-13 Gene Logic, Inc. Gene expression profiles in liver cancer
JP2004502417A (ja) * 2000-06-30 2004-01-29 アムジェン　インコーポレーテッド Ｂ７様分子およびその使用
EP1311662A2 (en) * 2000-08-24 2003-05-21 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
US20030124579A1 (en) * 2001-09-05 2003-07-03 Eos Biotechnology, Inc. Methods of diagnosis of ovarian cancer, compositions and methods of screening for modulators of ovarian cancer

Also Published As

Publication number Publication date
WO2004071530A2 (en) 2004-08-26
WO2004071530A3 (en) 2005-05-12
EP1589997A2 (en) 2005-11-02
NZ542206A (en) 2008-04-30
US20060140961A1 (en) 2006-06-29
MXPA05008293A (es) 2005-10-18
CA2515115A1 (en) 2004-08-26
AU2004211958A1 (en) 2004-08-26
US20060147374A1 (en) 2006-07-06
ZA200506507B (en) 2006-12-27
US20040258696A1 (en) 2004-12-23
KR20050105459A (ko) 2005-11-04

Similar Documents

Publication Publication Date Title
JP4822710B2 (ja) 腫瘍の診断と治療のための組成物と方法
JP4912356B2 (ja) 腫瘍の診断及び治療のための組成物及び方法
US7767403B2 (en) Compositions and methods for the diagnosis and treatment of tumor
JP4703567B2 (ja) 膠細胞起源の腫瘍の診断と治療のための組成物と方法
JP5587841B2 (ja) 造血系起源の腫瘍の治療のための組成物と方法
US20050064492A1 (en) Compositions and methods for the diagnosis and treatment of tumor
JP2005536439A (ja) 腫瘍の診断及び治療のための組成物と方法
JP2008137989A (ja) 腫瘍の診断と治療のための組成物と方法
JP2006516089A (ja) 腫瘍の診断と治療のための組成物と方法
JP2006516192A (ja) 腫瘍の診断と治療のための組成物と方法
JP2006500009A (ja) 腫瘍の診断と治療のための組成物と方法
JP2010154864A (ja) 造血系起源の腫瘍の治療のための組成物と方法
JP2010154864A6 (ja) 造血系起源の腫瘍の治療のための組成物と方法
JP2007519632A5 (enExample)
JP2008500949A (ja) 腫瘍の診断と治療のための組成物と方法
JP2005537810A (ja) 腫瘍の診断と治療のための組成物と方法
JP2007521791A (ja) 腫瘍の診断と治療のための組成物と方法
US20080096215A1 (en) Compositions and methods for the diagnosis and treatment of tumor
US20070098634A1 (en) Compositions and methods for the diagnosis and treatment of tumor
JP2006104212A (ja) 腫瘍の診断と治療のための組成物と方法
US20060140961A1 (en) Compositions and methods for the diagnosis and treatment of tumor
US20070041983A1 (en) Method for treating tumors using anti-osteopontin antibodies
JP2005513084A (ja) 腫瘍の診断と治療のための組成物及び方法
JP2005523311A (ja) 腫瘍の診断と治療のための組成物と方法
JP2011019523A (ja) 造血系起源の腫瘍の治療のための組成物と方法

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20070205

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20070205

A761 Written withdrawal of application

Free format text: JAPANESE INTERMEDIATE CODE: A761

Effective date: 20081218